Related Experiment Video
Updated: May 19, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Dapsone induced eosinophilic pneumonia
T Adar1, O Tayer-Shifman, M Mizrahi
1Internal Medicine A Department of Medicine, Hadassah-Hebrew University Medical Center Jerusalem, Israel. adartom@szmc.org.il
Abstract:
Eosinophilic lung diseases (ELD) are a variety of several clinical entities, which may result from different etiologies, including drug treatment. Dapsone, a sulfone antibiotic widely used in leprosy (among other indications), has been described as a possible cause of ELD. We report a patient with leprosy who presented with respiratory symptoms and pulmonary infiltrates and was diagnosed as suffering from eosinophilic pneumonia. To the best of our knowledge, this is the first report in which the diagnosis of dapsone-induced eosinophilic pneumonia was supported by bronchoalveolar lavage, lung biopsy and typical response to therapy.
Related Concept Videos
Atypical Pneumonia
Diphtheria
Chronic Obstructive Pulmonary Disease II: Emphysema
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
